Taurine As a Biomarker for Prediction of Response to Biologic Therapy in Rheumatoid Arthritis

被引：0
|
作者：
Takahashi, Soshi [1 ]
Saegusa, Jun [2 ]
Naka, Ikuko [1 ]
Tsuda, Kosaku [1 ]
Okano, Takaichi [1 ]
Akashi, Kengo [1 ]
Nishida, Miwa [1 ]
Nishimura, Keisuke [2 ]
Sendo, Sho [2 ]
Ueda, Yo [1 ]
Onishi, Akira [3 ]
Kogata, Yoshinori [2 ]
Kageyama, Goichi [2 ]
Morinobu, Akio [2 ]
机构：
[1] Kobe Univ Hosp, Dept Rheumatol, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Rheumatol & Clin Immunol, Kobe, Hyogo 657, Japan
[3] Kobe Univ, Grad Sch Med, Rheumaol & Clin Immunol, Kobe, Hyogo 657, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
535
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Integrating imaging and biomarker assessment to better define psoriatic arthritis and predict response to biologic therapy
    Elliott, Ashley
    McGonagle, Dennis
    Rooney, Madeleine
    RHEUMATOLOGY, 2021, 60 : VI38 - VI52
  • [42] Prediction of response to methotrexate in rheumatoid arthritis
    Ling, Stephanie
    Bluett, James
    Barton, Anne
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 419 - 429
  • [43] Biologic therapy response and drug survival for females compared to males with rheumatoid arthritis: a cohort study
    Lee, Jeffrey
    Mason, Randal
    Martin, Liam
    Barnabe, Cheryl
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (10) : 1449 - 1453
  • [44] STRATIFIED MEDICINE FOR RHEUMATOID ARTHRITIS: PREDICTING RESPONSE TO BIOLOGIC THERAPY USING IMMUNE CELL SIGNATURES
    Radley, Gemma
    Mulhearn, Ben
    Donlin, Laura
    Anolik, Jennifer H.
    Brenner, Michael
    Raychaudhuri, Soumya
    Hyrich, Kimme
    Morgan, Ann
    Wilson, Gerry
    Isaacs, John
    Hussell, Tracy
    Barton, Anne
    Viatte, Sebastien
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1094 - 1095
  • [45] Biologic therapy response and drug survival for females compared to males with rheumatoid arthritis: a cohort study
    Jeffrey Lee
    Randal Mason
    Liam Martin
    Cheryl Barnabe
    Rheumatology International, 2014, 34 : 1449 - 1453
  • [46] THE SIGNIFICANCE OF SERUM IGA IN RHEUMATOID ARTHRITIS IN THE ERA OF BIOLOGIC THERAPY
    Nakashima, A.
    Takeshi, Z.
    Ogane, K.
    Yamada, K.
    Kawano, M.
    Yachie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 404 - 404
  • [47] Combination therapy with biologic agents in rheumatoid arthritis: Perils and promise
    Kremer, JM
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : 1548 - 1551
  • [48] Use of Biologic Therapy As Monotherapy in Patients with Rheumatoid Arthritis.
    Gomez-Centeno, Antonio
    Martinez, Olga
    Javier Ballina, Francisco
    Manuel Rodriguez, Jose
    Grana, Jenaro
    Brito, Manuel
    Sampedro, Juana
    Iglesias, Gerardo
    Delgado, Concepcion
    Monteagudo, Indalecio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1082 - S1083
  • [49] What are the risks of biologic therapy in rheumatoid arthritis? An update on safety
    Weisman, MH
    JOURNAL OF RHEUMATOLOGY, 2002, 29 : 33 - 38
  • [50] Surgery of the Wrist and of the Hand in Rheumatoid Arthritis at the Time of Biologic Therapy
    Merle, Michel
    E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE, 2015, 14 (02): : 36 - 44
12345